# Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

> **NCT06125262** · — · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Immunotherapy
- Chemotherapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06125262
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125262, "Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06125262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*